This website uses cookies to enhance the user experience.
EP

Erlend Petter Skagseth1955

Shareholdings
1
7
Norway Business roles
16

Roles

Boards

NameRoleTotal operating incomeTotal equityShares
M
MITOSIS AS
Contact Person
-
5,454,063
100 %
directly
S
SARSIA IV AS
Chairman
-
-31,888
15.77 %
indirectly
A
APIM THERAPEUTICS AS
Chairman
64,960
20,194,781
0.91 %
indirectly
R
RECCURA THERAPEUTICS AS
Chairman
-
774,508
-
S
SERCA PHARMACEUTICALS AS
Chairman
4,714,624
27,645,238
-
A
AVEXXIN ONCOLOGY AS
Chairman
-
-78,133
-
S
STIFTELSEN SINTEF
Alternate Member
369,543,000
3,199,895,000
-
S
SEAFARM SOLUTIONS AS
Board Member
152,750
1,347,958
-
C
CONNECT VEST
Board Member
5,257,202
1,938,608
-
Board Member
-
-
-
C
CAEDO ONCOLOGY AS
Chairman
-
28,581,779
-
S
SINTEF AS
Alternate Member
2,710,260,013
837,850,205
-
S
SARSIA FOND III AS
Board Member
-
54,658,348
-
C
CALLUNA PHARMA POOLCO AS
Chairman
-
387,173,707
-
M
MED STORM INNOVATION AS
Board Member
4,970,331
-83,974
-
Last update: Aug 23, 2024

Shares owned by Erlend Petter Skagseth

NameShare classTotal operating incomeTotal equityShare
M
MITOSIS AS
Ordinære aksjer
0
5,454,063
100 %
directly
S
SARSIA MANAGEMENT AS
24,404,210
8,720,742
15.77 %
indirectly
S
SARSIA IV AS
0
-31,888
15.77 %
indirectly
S
SARSIA SEED AS
0
18,259,887
3.25 %
indirectly
A
AQUILOZ AS
0
-674,876
1.03 %
indirectly
A
APIM THERAPEUTICS AS
64,960
20,194,781
0.91 %
indirectly
S
SEA-HAWK NAVIGATION AS
5,326,348
235,971
0.68 %
indirectly
P
PROPHYLIX PHARMA HOLDING AS
0
19,595,007
0.62 %
indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025